Next Generation Sequencing Market Size By Product Type (Instruments, Consumables, Services), By Application (Research Application, Clinical Application {Cardiovascular, Reproductive Health, Cancer, Infectious Diseases}), By Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing), By End-use (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Feb 2021  |  Report ID: GMI3247  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 218   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Next Generation Sequencing Market size was valued more than USD 5.8 billion in 2020 and is expected to witness a 21.2% CAGR from 2021 to 2027. Improving reimbursement and regulatory scenario for next generation sequencing based diagnostic tests will prove beneficial for the market growth. Favourable funding scenario for genomics research across the globe will provide lucrative growth opportunities. Development of cost-effective next generation sequencing services and products for researchers accelerates the overall market expansion. Several market players such as Thermo Fisher, Illumina and others have geared up to fight against the COVID-19 outbreak with the help of genome sequencing.
 

Next Generation Sequencing Market
Get more details on this report - Request Free Sample PDF
 

Next generation sequencing technologies enable sequencing of RNA and DNA robustly and cheaply. These technologies are used to assess DNA and RNA samples and are popular in functional genomics. Next generation sequencing market share will expand across the clinical applications.
 

Next generation sequencing refers to large-scale DNA sequencing tools that help in exploration of whole genome. Next-generation sequencing (NGS) also called high-throughput sequencing is used to describe various modern sequencing technologies. These technologies allow for sequencing of RNA and DNA quickly than traditionally used Sanger sequencing.
 

Rising R&D activities for developing novel next generation sequencing technologies will boost the market revenue

Rising R&D activities for producing therapies utilized in treatment of genetic disorders will escalate the need for next generation sequencing method over the analysis period. Increasing investments in R&D activities and rising number of studies related to treatment of genetic disorders among individuals will create a huge market demand. Governments of developed economies have launched several policies and initiated acts for encouraging scientists and researchers to find solutions for treating chronic and rare ailments.
 

Consumables segment will dominate the market due to cost effectiveness and high replacement rate

The consumables segment dominated more than 60% of the next generation sequencing market share in 2020. Consumables have short durability, thus there is high replacement rate that upsurges the demand for consumables. Also, consumables are ordered in abundant quantity from several producers as it is proven as a cost-effective way for researchers as well as scientists that enhances the market value. Major industry manufacturers are taking numerous efforts in developing innovative consumables that will help researchers gain accurate results, augmenting the industry expansion.
 

Research application segment will observe substantial growth

The research application is anticipated to showcase around 21% growth rate till 2027. The researchers use whole genome, exome and targeted sequencing to develop medicines on several conditions such as cardiomyopathies, inherited cancer and retinitis pigmentosa impelling the market progression. Scientists have found out treatments and solutions even for the uncurable diseases with the usage of next generation sequencing techniques, creating strong demand in the market.
 

Several advantages associated with whole genome sequencing will spur the segment growth

Next Generation Sequencing Market Share

Get more details on this report - Request Free Sample PDF
 

The whole genome sequencing segment accounted for 27% of the next generation sequencing market share in 2020. Whole genome sequencing enables to identify, copy number of variants and has a wide range of approaches to examine and identify the impact of DNA sequence variations on human diversity, securing the market position. In addition, it captures large and small variants and identifies potential other variants for additional studies of gene expression, fuelling the market growth. Also, WGS delivers large volumes of data in a short time to help the assembly of novel genomes, surging its adoption rate.
 

Growing application of ion semiconductor sequencing technology will escalate the segment revenue

The ion semiconductor sequencing segment exceeded USD 697 million in 2020. Ion semiconductor sequencing technology is sophisticated, quick and cost effective as compared to other DNA sequencing technologies, influencing the segment progression. Similarly, ion semiconductor sequencing has several applications in transcriptome sequencing, exome sequencing, DNA and RNA sequencing, microbial genome sequencing, gene expression profiling, and viral and bacterial typing. Thus, wide range of applications of ion semiconductor sequencing technique will surge its industry growth.
 

Increasing advantages of next generation sequencing techniques in hospitals will drive its acceptance rate

The academic institutes & research centers end-use segment held 45% of the market share in 2020. Hospitals prefer next generation sequencing techniques due to their ability to provide clinical diagnosis in less time, favouring the market expansion. Also, next generation sequencing method can be used to gather the latest data and identification of transmission linkages to prevent infections across hospital settings that will prove beneficial for the market revenue.
 

Presence of leading industry players in North America region proves beneficial for the market value

North America next generation sequencing market

Get more details on this report - Request Free Sample PDF
 

North America next generation sequencing market is estimated to attain a CAGR of over 21% CAGR through 2027. Rising prevalence of cancer and genetic diseases will surge the adoption of advanced next generation sequencing instruments, fostering the market demand. Furthermore, various market leaders are focusing on developing technologically advanced next generation sequencing products that will escalate the industry value.
 

Strategic initiatives undertaken by key market participants have helped them to maintain their financial stability

Some of the prominent companies operating in the market include Agilent, BGI, Illumina, Qiagen, Roche and Thermo Fisher Scientific among others. These industry leaders are undertaking various growth strategies to garner higher revenue share in the industry.
 

  • In March 2019, BGI Genomics signed a service agreement with genomiQa for WGS on DNBseq. This agreement helped patients to access actionable information, thereby attracting larger customer base.
     
  • In May 2018, Agilent Technologies acquired Advanced Analytical Technologies, Inc. This strategic acquisition enhanced Agilent’s existing technology and expertise to provide customers with comprehensive NGS solutions.
     

The next generation sequencing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product Type, 2016-2027 (USD Million)

  • Instruments
  • Consumables
  • Services

Market, By Type, 2016-2027 (USD Million)

  • Whole genome sequencing
  • Exome sequencing
  • Targeted sequencing
  • Others

Market, By Application, 2016-2027 (USD Million)

  • Research application
  • Clinical application
  • Others

Market, By Technology, 2016-2027 (USD Million)

  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Others

Market, By End-use, 2016-2027 (USD Million)

  • Academic institutes & research centers
  • Hospitals & clinics
  • Pharmaceutical & biotechnology companies
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

 

Frequently Asked Questions (FAQ) :

Next generation sequencing market revenue surpassed USD 5.8 billion in 2020 and will grow at a CAGR of 21.2% CAGR through 2027.
Consumables segment captured over 60% of next generation sequencing industry share and will grow as they have a short life span and thus high replacement rate.
Next generation sequencing market revenue from research application will grow at a nearly 21% rate as it helps scientists to find treatment and solutions for varied diseases.
Whole genome sequencing segment held 27% of revenue share in 2020 and will expand substantially as it helps in delivering huge data in a short time for assembling novel genomes.
North America next generation sequencing industry size is set to grow at 21% CAGR through 2027 due to rising incidences of genetic diseases and cancer in the region.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Feb 2021
  • Pages: 218
  • Tables: 348
  • Charts / Figures: 11
  • Companies covered: 13
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X